How are nonprofit organizations leveraging venture philanthropy to accelerate the development of treatments and cures? As part of The Research Acceleration and Innovation Network (TRAIN) webinar series, FasterCures takes a deeper dive into the venture philanthropy approach of EB Research Partnership, the largest global nonprofit organization dedicated to treating and curing Epidermolysis Bullosa (EB). To date, EB Research Partnership has funded 80 research projects, which has led to 30 clinical trials, including 3 Phase III trials.
Kristin Schneeman, Program Director, FasterCures
Panel Experts and Speakers
Michael Hund, CEO of EB Research Partnership
Alex Silver, Chairman of EB Research Partnership
Daniel de Boer, CEO of ProQR Therapeutics
Mark de Souza, CEO of Wings Therapeutics
For more information about the conference call, click here.